On 1 November 2018 the law changed to allow doctors on the General Medical Council’s Specialist Register to prescribe unlicensed cannabis-based products for medicinal use (CBPM), where it is clinically appropriate and in the best interest of patients.

About Us

Our business represents the efforts of many whose vision is to improve the quality of life for those suffering from pain and ailments. We aim to create a recognised global consumer brand firmly associated with wellness from nature and to be philanthropic and profitable in a respectable balance.

Medicaleaf™ was founded by a team of business leaders, marketing & technology experts, scientists, caregivers and advocates who are committed to producing safe, reliable products and promoting wellness from nature.

Medicaleaf will have a ‘post-raise’ valuation of £20 million with expectations to reach a pre-floatation valuation of £100 million in three years, with an Annual predicted net profit over sales metric of ‘plus 43%’.

MedicalLeaf is already at the forefront of CBD product development and is ready for the impending Gold Rush.

“Regulation on a global scale is coming. Cannabinoids are on the verge of being used in toothpaste, beverages, personal care products, and almost anything else you can imagine” – Forbes August 2020

Would You Like to Know More?

Receive more information about this franchise opportunity direct from the franchisor by clicking the link below:

Add to Request List There is no cost or obligation associated with this service.

Key Facts:

Available across the UK
Business Type:
Business Opportunity
Minimum Investment:
Training Provided:
Part time:
Funding Support:
Complete Your Request